$SERV
Serve Robotics Inc. /DE/ Stock $serv

$serv Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023087177 Filed on November 15, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$42.72K	$62.57K
YoY Change
Cost Of Revenue	$399.1K	$572.5K
YoY Change		67.65%
Gross Profit	-$356.4K	-$510.0K
YoY Change		65.48%
Gross Profit Margin	-834.22%	-815.11%
Selling, General & Admin	$2.509M	$1.547M
YoY Change		1054.93%
% of Gross Profit
Research & Development	$2.712M	$2.963M
YoY Change		-9.17%
% of Gross Profit
Depreciation & Amortization	$467.0K	$465.6K
YoY Change
% of Gross Profit
Operating Expenses	$4.996M	$5.068M
YoY Change		1.03%
Operating Profit	-$5.352M	-$5.578M
YoY Change		41509.76%
Interest Expense	-$242.4K	$1.483M
YoY Change		4248.59%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$2.068M
YoY Change		5962.92%
Pretax Income	-$7.063M	-$7.646M
YoY Change
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$7.063M	-$7.646M
YoY Change		56938.21%
Net Earnings / Revenue	-16534.15%	-12220.85%
Basic Earnings Per Share		-$0.41
Diluted Earnings Per Share	-$0.19	-$0.41
COMMON SHARES
Basic Shares Outstanding	24.83M shares	5.000M shares	5.000M shares
Diluted Shares Outstanding		18.53M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.760K	$3.502M
YoY Change
Cash & Equivalents	$6.756K	$3.502M	$457.00
Short-Term Investments
Other Short-Term Assets	$677.0K	$750.1K
YoY Change
Inventory	$774.3K	$868.7K	$618.3K
Prepaid Expenses	$677.0K	$750.1K	$81.34K
Receivables	$2.955K	$3.955K	$23.70K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.461M	$5.125M	$457.00
YoY Change	319600.0%	404070.98%	68.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.42K	$1.982M	$3.376M
YoY Change	-98.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$512.7K	$512.7K
YoY Change
Total Long-Term Assets	$1.344M	$3.389M	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$1.461M	$5.125M	$457.00
Total Long-Term Assets	$1.344M	$3.389M	$0.00
Total Assets	$2.805M	$8.514M	$457.00
YoY Change	613586.87%	671325.47%	68.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.051M	$944.5K	$10.00K
YoY Change	20406.05%	9344.87%	33.33%
Accrued Expenses	$255.8K	$159.6K	$37.43K
YoY Change	583.47%
Deferred Revenue	$0.00
YoY Change
Short-Term Debt	$70.00K	$151.5K
YoY Change
Long-Term Debt Due	$3.364M	$3.082M
YoY Change
Total Short-Term Liabilities	$6.237M	$4.856M	$124.0K
YoY Change	4930.02%	4162.24%	71.13%
LONG-TERM LIABILITIES
Long-Term Debt	$230.9K	$813.9K
YoY Change
Other Long-Term Liabilities	$369.8K	$474.6K
YoY Change
Total Long-Term Liabilities	$600.7K	$1.288M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.237M	$4.856M	$124.0K
Total Long-Term Liabilities	$600.7K	$1.288M
Total Liabilities	$6.838M	$6.145M	$124.0K
YoY Change	5414.48%	5293.08%	71.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$68.33M	-$61.27M	-$124.0K
YoY Change	54989.27%	54039.71%	70.65%
Common Stock	$2.450K	$2.436K	$500.00
YoY Change	390.0%	387.2%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.033M	$2.369M	-$123.5K
YoY Change
Total Liabilities & Shareholders Equity	$2.805M	$8.514M	$457.00
YoY Change	613586.87%	671325.47%	68.63%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$7.063M	-$7.646M
YoY Change		56938.21%
Depreciation, Depletion And Amortization	$467.0K	$465.6K
YoY Change
Cash From Operating Activities	-$3.677M	-$5.704M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	$2.420K	$2.490K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$2.420K	-$2.490K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	183.6K	9.190M
YoY Change
NET CHANGE
Cash From Operating Activities	-3.677M	-5.704M
Cash From Investing Activities	-2.420K	-2.490K
Cash From Financing Activities	183.6K	9.190M
Net Change In Cash	-3.495M	3.483M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$3.677M	-$5.704M
Capital Expenditures	$2.420K	$2.490K
Free Cash Flow	-$3.679M	-$5.707M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56237
	dei	Entity Registrant Name EntityRegistrantName	SERVE ROBOTICS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3844872
	dei	Entity Address Address Line1 EntityAddressAddressLine1	730 Broadway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94063
	dei	City Area Code CityAreaCode	(818)
	dei	Local Phone Number LocalPhoneNumber	860-1352
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24832814	shares
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3502140	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2715719	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3955	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23697	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	868721	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	618262	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	750072	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	81339	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	5124888	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3439017	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1982001	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3376427	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	894127	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1215968	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	512659	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	512659	usd
CY2023Q3	us-gaap	Assets Assets	8513675	usd
CY2022Q4	us-gaap	Assets Assets	8544071	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	944487	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	162034	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	159648	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37434	usd
CY2023Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1000000	usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1000000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	518877	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483186	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2081882	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2214348	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4856394	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3897002	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	476850	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1214600	usd
CY2022Q4	patr	Simple Agreements For Future Equity SimpleAgreementsForFutureEquity	13150745	usd
CY2023Q3	patr	Restricted Stock Award Liability RestrictedStockAwardLiability	159716	usd
CY2022Q4	patr	Restricted Stock Award Liability RestrictedStockAwardLiability	162747	usd
CY2023Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	314829	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	708143	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	337087	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1862980	usd
CY2023Q3	us-gaap	Liabilities Liabilities	6144876	usd
CY2022Q4	us-gaap	Liabilities Liabilities	20996217	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24689283	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7161654	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24362444	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6826352	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2436	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	683	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	63805874	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31232737	usd
CY2023Q3	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	168516	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	165719	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61270995	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43520645	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2368799	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-12452146	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8513675	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8544071	usd
CY2023Q3	us-gaap	Revenues Revenues	62565	usd
CY2022Q3	us-gaap	Revenues Revenues	33333	usd
	us-gaap	Revenues Revenues	164826	usd
	us-gaap	Revenues Revenues	60689	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	572537	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	341517	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1331165	usd
	us-gaap	Cost Of Revenue CostOfRevenue	721198	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-509972	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-308184	usd
	us-gaap	Gross Profit GrossProfit	-1166339	usd
	us-gaap	Gross Profit GrossProfit	-660509	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1428143	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	952553	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3414949	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2666005	usd
CY2023Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	558068	usd
CY2022Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	681434	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1672403	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1555841	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2962812	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3261785	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7171446	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9275252	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	118793	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	120537	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	481511	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	398635	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	5067816	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5016309	usd
	us-gaap	Operating Expenses OperatingExpenses	12740309	usd
	us-gaap	Operating Expenses OperatingExpenses	13895733	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5577788	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5324493	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13906648	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14556242	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1483390	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	34112	usd
	us-gaap	Interest Expense InterestExpense	2021996	usd
	us-gaap	Interest Expense InterestExpense	49028	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	149000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	149000	usd
CY2023Q3	patr	Change In Fair Value Of Simple Agreements For Future Equity ChangeInFairValueOfSimpleAgreementsForFutureEquity	435794	usd
	patr	Change In Fair Value Of Simple Agreements For Future Equity ChangeInFairValueOfSimpleAgreementsForFutureEquity	1672706	usd
	patr	Change In Fair Value Of Simple Agreements For Future Equity ChangeInFairValueOfSimpleAgreementsForFutureEquity	-4506	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2068184	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-34112	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3843702	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44522	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-7645972	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-5358605	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17750350	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14600764	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18528262	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6871200	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10674991	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6990773	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.09
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8320395	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	999999	usd
CY2022Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	49000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9026	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3942145	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5436275	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11057	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5300015	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	147317	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	817	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	93724	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-5358605	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-5116747	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-12452146	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2234	usd
CY2023Q1	patr	Restricted Stock Awards Repurchased RestrictedStockAwardsRepurchased	-4	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	93943	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5138122	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-17494095	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2131	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	106929	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4966256	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-22351291	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	12160560	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	3751875	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	17490404	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3140	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	991000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	103385	usd
CY2023Q3	us-gaap	Partners Capital Account Public Sale Of Units Net Of Offering Costs PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts	2134302	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-7645972	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2368799	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17750350	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14600764	usd
	us-gaap	Depreciation Depreciation	1396919	usd
	us-gaap	Depreciation Depreciation	40521	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	304256	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	113806	usd
	patr	Change In Fair Value Of Simple Agreement For Future Equity ChangeInFairValueOfSimpleAgreementForFutureEquity	1672706	usd
	patr	Change In Fair Value Of Simple Agreement For Future Equity ChangeInFairValueOfSimpleAgreementForFutureEquity	-4506	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	816715	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9167	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-991000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	149000	usd
	patr	Interest On Recourse Loan InterestOnRecourseLoan	2797	usd
	patr	Change In Accounts Receivable ChangeInAccountsReceivable	-19742	usd
	patr	Change In Accounts Receivable ChangeInAccountsReceivable	30980	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	250459	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5190776	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	517233	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	337276	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	782454	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2803257	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	129481	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2886	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-35782	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	210518	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12294348	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16984147	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2493	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83662	usd
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	389636	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2493	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-473298	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2666953	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10585002	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	750000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2500000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1500000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2798410	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	449000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-449000	usd
	patr	Repayment Of Lease Liability Financing RepaymentOfLeaseLiabilityFinancing	1658359	usd
	patr	Issuance Of Common Stock Pursuant To Merger Net Of Offering Costs IssuanceOfCommonStockPursuantToMergerNetOfOfferingCosts	10026258	usd
	patr	Issuance Of Series Seed Preferred Stock IssuanceOfSeriesSeedPreferredStock	999999	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13083262	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14085001	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations	786421	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations	-3372444	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2715719	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7965861	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3502140	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4593417	usd
	us-gaap	Interest Paid Net InterestPaidNet	258256	usd
	patr	Vested Restricted Stock Purchased With Recourse Notes VestedRestrictedStockPurchasedWithRecourseNotes	10302	usd
	patr	Derivative Liability In Connection With Convertible Note DerivativeLiabilityInConnectionWithConvertibleNote	601000	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	63840	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	17490404	usd
	patr	Conversion Of Convertible Note And Derivative Into Common Stock In Connection With Merger ConversionOfConvertibleNoteAndDerivativeIntoCommonStockInConnectionWithMerger	3751875	usd
	us-gaap	Stock Issued1 StockIssued1	49000	usd
	patr	Note Payable Related Party Of Predecessor NotePayableRelatedPartyOfPredecessor	-151500	usd
	us-gaap	Nature Of Operations NatureOfOperations	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NATURE OF OPERATIONS</b></span></td> </tr></table> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 31, 2023, the board of directors of Patricia Acquisition Corp., a Delaware corporation (“Patricia”) and all of its pre-Merger (as defined below) stockholders approved a restated certificate of incorporation, which was effective upon its filing with the Secretary of State of the State of Delaware on July 31, 2023, and through which Patricia changed its name to “Serve Robotics Inc.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Serve Operating Co. (formerly known as Serve Robotics Inc.) (the “Company” or “Serve”) is a corporation formed on January 15, 2021 under the laws of the State of Delaware. The Company is developing next generation robots for last-mile delivery services. The Company is headquartered in Redwood City, California.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the Company entered into a contribution and license agreement with Postmates, LLC, a Delaware limited liability company (“Postmates”). Pursuant to the agreement, Postmates transferred over certain contracts and agreements, intellectual property and patents and hardware and equipment to the Company. As the contribution was without consideration, the agreement did not have any effect on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 31, 2023, Patricia’s wholly-owned subsidiary, Serve Acquisition Corp., a corporation formed in the State of Delaware on July 10, 2023 (“Acquisition Sub”), merged with and into the Company. Pursuant to this transaction (the “Merger”), the Company was the surviving corporation and became Patricia’s wholly owned subsidiary, and all of the outstanding stock of Serve was converted into shares of Patricia’s common stock. All of Serve’s outstanding warrants and options were assumed by Patricia. Following the consummation of the Merger, Serve changed its name to “Serve Operating Co.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the closing of the Merger, Patricia Acquisition Corp. changed its name to Serve Robotics Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Merger, Patricia acquired the business of Serve and will continue the existing business operations of Serve as a public reporting company under the name Serve Robotics Inc. In accordance with “reverse merger” or “reverse acquisition” accounting treatment, the Company was determined the accounting acquirer. Patricia’s historical financial statements before the Merger has been replaced with the historical financial statements of Serve before the Merger in filings with the SEC since the Merger unless otherwise noted.</span></p>
	patr	Going Concern GoingConcern	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GOING CONCERN</b></span></p></td></tr> </table> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained net losses since inception and $17,750,350 during the nine months ended September 30, 2023, The Company used cash in operations of $12,445,848 during the nine months ended September 30, 2023. The Company requires additional capital to operate. These factors raise substantial doubt about the Company’s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company’s ability to continue as a going concern until it reaches profitability is dependent upon its ability to generate cash from operating activities and to raise additional capital to fund operations. There are no assurances than management’s plans will be successful.</p>
	us-gaap	Net Income Loss NetIncomeLoss	-17750350	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	12445848	usd
	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.8035	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, valuation of future equity obligations and stock-based compensation. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates. </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentrations of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. As of September 30, 2023 and December 31, 2022, the Company’s cash and cash equivalents were held at one accredited financial institution. As of September 30, 2023 and December 31, 2022, the Company had balances in excess of insured amounts, respectively.</p>
	patr	Revenue Percentage RevenuePercentage	0.68	pure
	patr	Delivery Revenue DeliveryRevenue	111784	usd
	patr	Branding Fees BrandingFees	45250	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	7792	usd
	patr	Delivery Revenue DeliveryRevenue	35049	usd
	patr	Branding Fees BrandingFees	25640	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	47700	usd
	us-gaap	Advertising Expense AdvertisingExpense	184000	usd
	us-gaap	Advertising Expense AdvertisingExpense	144000	usd
CY2023Q3	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Equity Securities FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentEquitySecurities	1	pure
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2064369	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9103044	shares
	patr	Common Stock Shares CommonStockShares	4372601	shares
CY2023Q3	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	7978616	shares
CY2023Q3	patr	Preferred Stock Converted Into Warrants PreferredStockConvertedIntoWarrants	128819	shares
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	13150745	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	4
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	4372601	shares
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	17490404	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	13150745	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2666953	usd
	patr	Issuance Of Embedded Derivative Liability IssuanceOfEmbeddedDerivativeLiability	601000	usd
	patr	Change In Fair Value ChangeInFairValue	1821706	usd
	patr	Conversion To Common Stock Before Apo ConversionToCommonStockBeforeAPO	-18240404	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3809528	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3807035	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1827527	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	430608	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1982001	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3376427	usd
	us-gaap	Depreciation Depreciation	1396919	usd
	us-gaap	Depreciation Depreciation	40521	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2666953	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	65000000	usd
	patr	Discount Rate DiscountRate	0.80	pure
CY2023Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	5405876	usd
CY2021Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	13150745	usd
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	18179115	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	257639	shares
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	999999	usd
CY2023Q3	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	7978616	shares
	patr	Convertible Note And Related Derivative Liability Converted Shares Of Common Stock ConvertibleNoteAndRelatedDerivativeLiabilityConvertedSharesOfCommonStock	937961	shares
CY2023Q3	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	7978616	shares
CY2022	patr	Shares Of Restricted Common Stock Issued SharesOfRestrictedCommonStockIssued	338121	shares
CY2022	patr	Restricted Common Stock For Recourse Notes RestrictedCommonStockForRecourseNotes	164116	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	165719	usd
CY2022Q4	patr	Restricted Stock Award Liability RestrictedStockAwardLiability	162747	usd
	patr	Shares Of Restricted Common Stock Vested For A Value SharesOfRestrictedCommonStockVestedForAValue	10302	usd
CY2023Q3	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	168516	usd
CY2023Q3	patr	Restricted Stock Award Liability RestrictedStockAwardLiability	159716	usd
	patr	Stock Based Compensation Pertaining To Vesting Of Restricted Common Stock StockBasedCompensationPertainingToVestingOfRestrictedCommonStock	218453	usd
	patr	Stock Based Compensation Pertaining To Vesting Of Restricted Common Stock StockBasedCompensationPertainingToVestingOfRestrictedCommonStock	72300	usd
	patr	Repurchased Restricted Stock Awards RepurchasedRestrictedStockAwards	301600	shares
	patr	Repurchase Shares Of Common Stock RepurchaseSharesOfCommonStock	240700	shares
CY2023Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1594800	shares
	patr	Percentage Of Common Stock Issued And Outstanding PercentageOfCommonStockIssuedAndOutstanding	0.04	pure
CY2023Q3	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	4870663	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3275863	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	861309	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	765477	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.75
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	31985	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.49
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1594800	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.61
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	296057	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.51
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1292215	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	170125	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P8Y9M14D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	85803	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41506	usd
	patr	Total Unrecognized Compensation TotalUnrecognizedCompensation	521000	usd
	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P3Y11M26D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0301	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.791	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	patr	Percentage Of Common Stock PercentageOfCommonStock	0.08	pure
	patr	Warrants Issued WarrantsIssued	468971	shares
	patr	Common Stock Fair Value CommonStockFairValue	4
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	3.2
	patr	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2	P3Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.75	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0418	pure
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	991000	usd
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1079290	shares
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	2.66
	us-gaap	Operating Lease Cost OperatingLeaseCost	756570	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	505060	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	411393	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	252997	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0725	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0725	pure
CY2022Q4	us-gaap	Proceeds From Sale Of Finance Receivables ProceedsFromSaleOfFinanceReceivables	3561288	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1658359	usd
	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	2418969	usd
CY2023Q3	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.40	pure
CY2023Q3	patr	Simple Agreements For Future Equity SimpleAgreementsForFutureEquity		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q3	patr	Change In Fair Value Of Simple Agreements For Future Equity ChangeInFairValueOfSimpleAgreementsForFutureEquity		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18528262	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6871200	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6990773	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.78
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.66
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.09
CY2022Q1	patr	Restricted Stock Awards Repurchased RestrictedStockAwardsRepurchased		usd
CY2022Q2	patr	Restricted Stock Awards Repurchased RestrictedStockAwardsRepurchased		usd
CY2022Q3	patr	Restricted Stock Awards Repurchased RestrictedStockAwardsRepurchased		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q3	patr	Predecessor Shares Converted Into Common Stock Upon The Merger PredecessorSharesConvertedIntoCommonStockUponTheMerger		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	patr	Interest On Recourse Loan InterestOnRecourseLoan		usd
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	patr	Repayment Of Lease Liability Financing RepaymentOfLeaseLiabilityFinancing		usd
	patr	Issuance Of Common Stock Pursuant To Merger Net Of Offering Costs IssuanceOfCommonStockPursuantToMergerNetOfOfferingCosts		usd
	patr	Issuance Of Series Seed Preferred Stock IssuanceOfSeriesSeedPreferredStock		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	patr	Vested Restricted Stock Purchased With Recourse Notes VestedRestrictedStockPurchasedWithRecourseNotes		usd
	patr	Derivative Liability In Connection With Convertible Note DerivativeLiabilityInConnectionWithConvertibleNote		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	patr	Conversion Of Convertible Note And Derivative Into Common Stock In Connection With Merger ConversionOfConvertibleNoteAndDerivativeIntoCommonStockInConnectionWithMerger		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	patr	Note Payable Related Party Of Predecessor NotePayableRelatedPartyOfPredecessor		usd
CY2023Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure		usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2023Q3	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1535230	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001832483

Files In Submission

Name	View Source	Status
patr-20230930_cal.xml	Edgar Link	unprocessable
patr-20230930_def.xml	Edgar Link	unprocessable
0001213900-23-087177-index-headers.html	Edgar Link	pending
0001213900-23-087177-index.html	Edgar Link	pending
0001213900-23-087177.txt	Edgar Link	pending
0001213900-23-087177-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_serverobotics.htm	Edgar Link	pending
f10q0923ex31-2_serverobotics.htm	Edgar Link	pending
f10q0923ex32-1_serverobotics.htm	Edgar Link	pending
f10q0923ex32-2_serverobotics.htm	Edgar Link	pending
f10q0923_serverobotics.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
patr-20230930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
patr-20230930_lab.xml	Edgar Link	unprocessable
f10q0923_serverobotics_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
patr-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SERV
Serve Robotics Inc. /DE/ Stock $serv

2023 Q4 Form 10-Q Financial Statement

#000121390023087177 Filed on November 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERV Serve Robotics Inc. /DE/ Stock $serv

2023 Q4 Form 10-Q Financial Statement

#000121390023087177 Filed on November 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERV
Serve Robotics Inc. /DE/ Stock $serv